comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 01:13:19 - browse：6295

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Why health workers in Gaza are injured or die at high rates

WSS

Study gives hint on South Asians’ higher risk of cardiovascular disease

Medicare reduced heart disease by changing how it pays doctors

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

STAT Summit: Michael J. Fox on progress in Parkinson's research

Why Eli Lilly’s earnings didn’t quite live up to the hype

First Opinion Podcast: Long Covid needs a new approach

knowledge

comprehensive

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Juul documents reveal insider tactics on political lobbying

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Long Covid research funding gets a major boost from NIH

State Dept. review finds Biden bears some blame for Afghanistan failures

Latigo launches with $135 million for Vertex

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare reduced heart disease by changing how it pays doctors

Sports medicine is finally prioritizing gender equality

Eli Lilly expects to double planned employment in Boston center

leisure time

The explosion of genetic testing requires a new approach

FDA warns J&J's Abiomed: We will regulate your software

Researchers explore possible ties between long Covid, menopause

FDA gives detailed accounting of AI

CEOs share strategies for surviving biotech slump

Studies point to risks of excluding people with obesity from drug trials

Wikipedia

entertainment

knowledge

knowledge